2018 Q4/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Cytogen
7.0
2 +0 Wockhardt
6.4
3 +0 Ligand Pharmaceuticals
6.2
4 +13 Genus
6.0
5 +2 Takeda
6.0
6 +0 Astellas Europe
6.0
7 +0 Shionogi
5.8
8 -4 Zambon
5.8
9 -4 Galenica AG
5.7
10 +3 Yakult UK
5.7
11 +14 Mitsubishi Tanabe
5.6
12 +2 Hetero
5.6
13 -4 Meda Pharmaceuticals
5.6
14 +30 Impax Laboratories
5.5
15 -4 Kyorin Holdings
5.5
16 +21 EISAI UK
5.5
17 +1 Julphar
5.4
18 +6 QLT
5.4
19 +11 Bavarian Nordic
5.3
20 -4 BTG International
5.3
21 -1 Zandu
5.3
22 -10 Pfizer UK
5.3
23 +15 Dainippon Sumitomo
5.2
24 -9 Actelion
5.2
25 -6 Takeda UK
5.2
26 +9 Apotex
5.1
27 -1 Vitrolife
5.1
28 -7 Abbott Uk
5.1
29 +0 Bosnalijek
5.0
30 +1 Laboratoires Thea UK
5.0
31 +1 Otsuka Pharmaceuticals Europe
5.0
32 +37 Stada
4.9
33 +3 Acorda Therapeutics
4.9
34 -11 ALK-Abello
4.8
35 +16 Recordati
4.8
36 +3 Mitsubishi Tanabe Pharma Europe Ltd
4.7
37 +3 Nissan Chemical
4.7
38 +3 Lilly
4.7
39 -5 Anavex Life Sciences Corp
4.7
40 +2 Toray Industries
4.7
41 +4 Wockhardt UK
4.6
42 +49 Avanir Pharmaceuticals
4.6
43 +3 Bial Portela
4.6
44 +31 Boehringer Ingelheim
4.6
45 +7 Mochida
4.5
46 +39 Meiji Holdings
4.5
47 +18 Bayer UK & Ireland
4.5
48 +20 Kaken Pharmaceutical
4.5
49 +17 Leo Pharma UK
4.5
50 -1 GlaxoSmithKline
4.4


Changes in rank are compared to 2018 Q3/Global Life Sciences. Since then, 2 sites entered the survey and 83 sites could not be included in the rankings (3 more since last time). Build your own. Report statistics.